Fusidic acid/Betamethasone
夫西地酸倍他米松
Report date: 2025/12/05 14:17:39
NME
Base Information
Drug NameFusidic acid/Betamethasone
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes BetamethasoneFusidic acid
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesLeo Pharma Consultancy(Shanghai)Company LtdLeo Laboratories Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A